In several neurodegenerative disorders such as Parkinson's disease and Huntington's disease, neuronal systems employing the neurotransmitter dopamine have been implicated in either the pathology or the drug treatments of the disease (for review see [ 11) . It is therefore of some importance to understand the mechanism of action of dopamine in controlling brain function, both in the normal state and in disease states. 
In several neurodegenerative disorders such as Parkinson's disease and Huntington's disease, neuronal systems employing the neurotransmitter dopamine have been implicated in either the pathology or the drug treatments of the disease (for review see [ 11) . It is therefore of some importance to understand the mechanism of action of dopamine in controlling brain function, both in the normal state and in disease states. When the amino acid sequences of the receptor subtypes, derived from the DNA sequence, were analysed, each conformed to the now classical model, typical of a G-protein-linked receptor: seven putative transmembrane spanning (a-helical) regions, linked by loops of protein outside the membrane. The seven a-helices are thought to cluster within the membrane to form the ligandbinding site and models for this have been proposed (for example, see [S] ). There is significant amino acid homology between the dopamine receptor subtypes; this is greater between members of one subgroup (e.g. D,/D,) than between members of different subgroups (e.g. D,/D,). 
Multiple dopamine receptors

Neuronal localization of dopamine receptors in the neostriatum
In order to understand the role of dopamine and dopamine receptors in normal brain function and in neurodegenerative disorders, it is important to define the neuronal localization of the subtypes. Here I shall confine the discussion to the basal ganglia, and in particular the neostriatum (caudate nucleus/putamen), since this part of the brain is important for understanding Parkinson's and Huntington's diseases. This discussion will also largely concern D, and DL dopamine receptors as these are the principal dopamine receptor subtypes in the neostriatum.
The neostriatum contains several neuronal cell types. The predominant neuronal cell type is the medium spiny cell, which forms the principal outflow pathway of the neostriatum and constitutes about 95% of the neuronal cells in the neostriatum [ 11 1. Medium spiny cells contain the neurotransmitter y-aminobutyrate (GAHA). About half the cells also contain the co-existing neuropeptide substance P, the other half additionally contain the neuropeptide enkephalin. This chemical differentiation of medium spiny cells seems to parallel an anatomical differentiation. GAHA/substance P-containing medium spiny neurones form the so-called 'direct' pathway, linking the neostriatum to the two principal outlow nuclei of the basal ganglia, the substantia nigra pars reticulata and the globus pallidus internal segment (SN,/CPi). GABA/enkephalincontaining medium spiny cells form the first part of the 'indirect' pathway, linking the neostriatum to SN,/GP, via the globus pallidus external segment (GPe) and subthalamic nucleus. In addition to the medium spiny cells, there are a number of minor neuronal populations including a population of aspiny cholinergic cells. For more detailed reviews ofthis see 112-141.
The distribution of dopamine receptor subtypes within the neostriatum has been defined in several ways. Studies at the mRNA level using in situ hybridization have shown that the D, and D, receptors are located preferentially on the GARA/ substance P-and GARAIenkephalin-containing medium spiny neurones [lS, 161, although there may be some medium spiny neurones containing both receptor subtypes respectively [ 15, 17, 181. These studies, therefore, suggest a differential expression of dopamine receptor subtypes on neuronal populations in the neostriatum. In contrast, recent work has been reported that suggests extensive colocalization of dopamine receptor subtypes on single neurones in the neostriatum. Amplification of mRNA, aspirated from single striatonigral neurones, showed the presence of D,, D, and D, receptor mRNA, although the levels of D, receptor mRNA were the highest [21] . Since mRNA for a species may be present but not expressed as active receptor protein, several groups have also been working to obtain antibodies specific for the different dopamine receptor subtypes (see for example [22, 231) . Immunofluorescent analysis of the distribution of D, and D, receptors showed that medium spiny neurones expressed both D, and DZ receptor protein whether the chemical subtype was GAHA/substance P or GARAIenkephalin [24] . These suggestions of colocalization of several dopamine receptor subtypes on single neurones, are consistent with some biochemical and functional studies which show that dopamine acting on D, and DL receptors can influence the activity of the same neurone (reviewed in 1251).
It is difficult at present to reconcile these two conflicting views on receptor localization in the neostriatum. Surmeier et al.
[25] have proposed that, whereas dopamine receptor subtypes are colocalized in a large proportion of medium spiny neurones, this colocalization is only expressed at the neuronal cell body and dendrites. At the nerve terminals there is segregation of receptor subtypes so that the terminals of GAHAIsubstance P-containing cells contain D, receptors and the terminals of GABA/enkephalin cells contain I)? receptors. 
Role of the neostriatum in control of movement
The studies outlined above are important for understanding movement disorders because of the critical role of the neostriatum in controlling voluntary movement. The direct and indirect neostriatal efferent pathways play opposing roles; activity in the direct pathway ultimately facilitates movement, activity in the indirect pathway inhibits movement. Therefore, some kind of balance between the two neostriatal efferent pathways needs to be maintained if movement is to be facilitated overall, in favour of the direct pathway. Dopamine (released from mesostriatal neurones projecting to the neostriatum from the substantia nigra pars compacta) may achieve this balance. Dopamine has been shown to facilitate neuronal activity in the direct pathway and inhibit that in the indirect pathway. Evidence for this comes from studies on the electrophysiological activity of neostriatal neurones in animals with dopamine lesions (reviewed in [XI), glucose utilization by neostriatal neurones Nevertheless, there is evidence that dopamine does facilitate activity in the direct pathway, and inhibit activity in the indirect pathway. There is also evidence that occupancy of D, and D, receptors is required for full expression of movement [30] . As outlined earlier, whether D, and D, dopamine receptors are segregated or not, mechanisms can be proposed for selective effects of D, and D, agonists on different neostriatal neuronal populations and hence the direct and indirect pathways respectively. It seems that for adequate control of movement, an appropriate balance must be set between the activities of the direct and indirect neostriatal efferent pathways and both D, and D, dopamine receptors must be occupied. These two requirements may be linked as outlined above.
Relevance to neurodegenerative disorders
Parkinson's disease
In Parkinson's disease the principal neurodegenerative change is the loss of the mesostriatal dopamine innervation from the substantia nigra pars compacts to the neostriatum. If dopamine is important in maintaining a balance between the direct and indirect neostriatal output pathways, as indicated above, then loss of dopamine will shift the system towards a state where the indirect pathway predominates. Since this is inhibitory for movement, the relative paucity of movement in Parkinson's dis- 
Huntington's disease
Although in the late stages of Huntington's disease there are extensive neuronal losses and brain shrinkage (especially in the neostriatum), in the early stages of the disease quite selective neuronal changes have been described [ 121. Early neuronal losses seem to be in the medium spiny neostriatal neurones forming the indirect pathway. This will shift the balance of neostriatal output in favour of the direct pathway so that there may be excessive facilitation of movement. This may account for the abnormal involuntary movements (chorea) these patients exhibit.
Although there is no effective treatment for Huntington's disease, some relief of choreic symptoms may be achieved by treatment with dopamine antagonists. Since dopamine tends to poise neostriatal output pathways in favour of the direct pathway, dopamine antagonism will reduce this effect and may partially reduce the predominance of the direct pathway.
The author wishes to thank Sue Davies for excellent manuscript preparation.
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Introduction
Astrocytosis, vacuolation of the neuropil and a progressive loss of neurones are the most common histological signs of scrapie, a transmissible (infectious) disease of sheep and goats [ 13. This type of neurodegenerative disorder is found in other mammalian species: Creutzfeldt-Jakob disease (CJD, in man); Gerstmann-Straussler syndrome (GSS, man); bovine spongiform encephalopathy (BSE, cattle), transmissible mink encephalopathy (mink); chronic wasting disease (mule, deer and elk); and feline spongiform encephalopathy (cats). The incubation period of the disease, following transmission by inoculation or feeding, varies with dose of exposure, route of infection, species (and genotype) of host or recipient and strain isolate of pathogen. These factors may also influence the average age of onset of natural disease (given in parentheses) and Abbreviations used: BSE, bovine spongiform encephalopathy; CJD, Creutzfeldt-Jakob disease; chPrP, chicken PrP; CNS, central nervous system; GSS, Gerstmann-Straussler syndrome; NMDA, N-methyl+-aspartate; TPCK, tosyl lysyl chloromethane. many years this biological variation confounded attempts to provide a molecular description of the neurodegenerative process.
In the 1960s, transmission of scrapie to inbred strains of mice simplified experimental approaches to these diseases and revealed a genetic locus (Sinc, with two alleles, s7 and p7) that determined the overall rate of pathogen replication and incubation period [5, 6] . Concurrently, over 20 different strains of scrapie were characterized by ranking the incubation periods, and the severity and location of vacuolar pathology which they produced in mice, of the three Sinc genotypes [l]. In some of these models, notably the 87V strain of scrapie in MB/ DK (Simp7) mice, large (40-100 pm) plaque-like deposits of congophilic amyloid were observed, similar (in morphology) to the amyloid plaques of Alzheimer's disease [7] . In retrospect, these congregations of sparingly soluble protein fibrils held the key to a molecular understanding of this type of neurodegenerative disease.
The PrP protein
The plaque fibrils are composed of PrPSc, an abnormal form of a phosphoinositol-glycolipid-anchored membrane glycoprotein (PrpC) found in the brain and, to a lesser extent, in other tissues [8] . In contrast to PrPC, P r P is relatively resistant to proteolysis by proteinase K in low, non-denaturing,
